News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
465,986 Results
Type
Article (17766)
Company Profile (79)
Press Release (448141)
Multimedia
Podcasts (27)
Webinars (4)
Section
Business (139940)
Career Advice (721)
Deals (26043)
Drug Delivery (81)
Drug Development (55873)
Employer Resources (78)
FDA (13371)
Job Trends (9940)
News (241101)
Policy (23275)
Tag
2024 BioCapital Digital (5)
2024 BioForest Digital (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (7)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (3)
2024 Genetown Standard (5)
2024 Lone Star Bio Digital (3)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (893)
Accelerated approval (3)
Adcomms (12)
Allergies (66)
Alliances (36412)
ALS (47)
Alzheimer's disease (758)
Antibody-drug conjugate (ADC) (67)
Approvals (13425)
Artificial intelligence (139)
Autoimmune disease (16)
Automation (13)
Bankruptcy (210)
Best Places to Work (8078)
BIOSECURE Act (13)
Biosimilars (96)
Biotechnology (51)
Bladder cancer (38)
Brain cancer (13)
Breast cancer (127)
Cancer (1299)
Cardiovascular disease (101)
Career advice (618)
Career pathing (9)
CAR-T (117)
Cell therapy (332)
Cervical cancer (14)
Clinical research (46665)
Collaboration (570)
Compensation (222)
Complete response letters (14)
COVID-19 (1453)
CRISPR (25)
C-suite (150)
Cystic fibrosis (58)
Data (1508)
Denatured (14)
Depression (23)
Diabetes (208)
Diagnostics (4284)
Digital health (11)
Diversity (1)
Diversity, equity & inclusion (8)
Drug discovery (71)
Drug pricing (62)
Drug shortages (26)
Duchenne muscular dystrophy (64)
Earnings (60229)
Editorial (19)
Employer branding (8)
Employer resources (63)
Events (66356)
Executive appointments (491)
FDA (14366)
Featured Employer (23)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (6)
Funding (410)
Gene editing (66)
Generative AI (11)
Gene therapy (221)
GLP-1 (478)
Government (2794)
Grass and pollen (5)
Guidances (43)
Healthcare (10660)
Huntington's disease (12)
IgA nephropathy (19)
Immunology and inflammation (61)
Indications (25)
Infectious disease (1548)
Inflammatory bowel disease (75)
Inflation Reduction Act (6)
Influenza (43)
Intellectual property (68)
Interviews (97)
IPO (11802)
IRA (28)
Job creations (2207)
Job search strategy (546)
Kidney cancer (8)
Labor market (15)
Layoffs (270)
Leadership (7)
Legal (4657)
Liver cancer (46)
Lung cancer (195)
Lymphoma (103)
Machine learning (3)
Management (39)
Manufacturing (298)
MASH (38)
Medical device (10641)
Medtech (10645)
Mergers & acquisitions (14669)
Metabolic disorders (463)
Multiple sclerosis (55)
NASH (8)
Neurodegenerative disease (44)
Neuropsychiatric disorders (9)
Neuroscience (1059)
NextGen: Class of 2025 (3581)
Non-profit (1192)
Northern California (1730)
Now hiring (12)
Obesity (235)
Opinion (129)
Ovarian cancer (39)
Pain (52)
Pancreatic cancer (49)
Parkinson's disease (87)
Partnered (11)
Patents (175)
Patient recruitment (67)
Peanut (36)
People (37365)
Pharmaceutical (33)
Pharmacy benefit managers (6)
Phase I (14070)
Phase II (20337)
Phase III (16164)
Pipeline (936)
Policy (81)
Postmarket research (1549)
Preclinical (5384)
Press Release (67)
Prostate cancer (68)
Psychedelics (14)
Radiopharmaceuticals (175)
Rare diseases (226)
Real estate (3919)
Recruiting (29)
Regulatory (17386)
Reports (24)
Research institute (892)
Resumes & cover letters (86)
Rett syndrome (3)
RNA editing (2)
RSV (27)
Schizophrenia (39)
Series A (60)
Series B (43)
Service/supplier (8)
Sickle cell disease (34)
Southern California (1503)
Special edition (9)
Spinal muscular atrophy (112)
Sponsored (18)
Startups (2260)
State (1)
Stomach cancer (2)
Supply chain (66)
Tariffs (25)
The Weekly (13)
United States (15322)
Vaccines (399)
Venture capitalists (14)
Weight loss (159)
Women's health (22)
Worklife (9)
Date
Today (61)
Last 7 days (402)
Last 30 days (1650)
Last 365 days (22770)
2025 (6752)
2024 (24701)
2023 (28822)
2022 (38469)
2021 (41283)
2020 (39335)
2019 (30890)
2018 (23550)
2017 (24366)
2016 (22275)
2015 (26561)
2014 (19120)
2013 (15768)
2012 (17534)
2011 (18246)
2010 (16020)
Location
Africa (396)
Alabama (32)
Alaska (2)
Arizona (100)
Arkansas (9)
Asia (30234)
Australia (4860)
California (3922)
Canada (1371)
China (397)
Colorado (162)
Connecticut (174)
Delaware (91)
Europe (62454)
Florida (610)
Georgia (164)
Hawaii (1)
Idaho (37)
Illinois (357)
India (20)
Indiana (244)
Iowa (5)
Japan (122)
Kansas (81)
Kentucky (6)
Louisiana (4)
Maine (64)
Maryland (637)
Massachusetts (2786)
Michigan (204)
Minnesota (235)
Mississippi (1)
Missouri (70)
Montana (20)
Nebraska (13)
Nevada (44)
New Hampshire (48)
New Jersey (1358)
New Mexico (23)
New York (1183)
North Carolina (647)
North Dakota (6)
Northern California (1730)
Ohio (136)
Oklahoma (8)
Oregon (25)
Pennsylvania (965)
Puerto Rico (10)
Rhode Island (21)
South America (738)
South Carolina (18)
South Dakota (1)
Southern California (1503)
Tennessee (70)
Texas (535)
Utah (96)
Virginia (113)
Washington D.C. (32)
Washington State (363)
West Virginia (3)
Wisconsin (32)
465,986 Results for "katena products".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Katena Products Announces the Acquisition of ASICO, LLC.
Katena Products, Inc. (Katena) a leading global provider of premium ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of ASICO, LLC (ASICO).
April 14, 2021
·
2 min read
Business
Katena Products Announces Steve Blazejewski as New CEO
Katena Products (“Katena”), a leading provider of ophthalmic instruments, biologics, and devices, is pleased to announce that Steve Blazejewski has joined as Chief Executive Officer.
December 7, 2020
·
2 min read
Deals
Katena Products Announces the Acquisition of Micro-Select Instruments, Inc.
Katena Products (“Katena”), a leading global provider of precision ophthalmic instruments, biologics, and devices to hospitals, surgical centers, and ophthalmic and optometric offices announces the purchase of Micro-Select Instruments Inc.(“Micro-Select”). Micro-Select was founded in 2005 by Lenny Moll and Mike Dorenkamp and is located in St. Clair, MO. The business specializes in manufacturing high precision ophth
October 20, 2020
·
2 min read
Press Releases
Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain
April 23, 2025
·
3 min read
Press Releases
NeuroPace Announces Refocusing of Product Portfolio
April 3, 2025
·
7 min read
Press Releases
Apnimed Provides Clinical Updates for Multiple Product Candidates
April 7, 2025
·
5 min read
Press Releases
Adragos Pharma Expands in Japan: Strengthening Production, Quality, and Trust
April 8, 2025
·
1 min read
Press Releases
ImmuCell Announces Initiation of Investigational Product Use of Re-Tain®
April 3, 2025
·
6 min read
Press Releases
Nuclera Expands eProtein Discovery Capabilities to Enable Membrane Protein Production
April 14, 2025
·
2 min read
Press Releases
MustGrow Adds New Biostimulants and Inoculants to Canadian Product Portfolio
April 1, 2025
·
5 min read
1 of 46,599
Next
